166 related articles for article (PubMed ID: 6247661)
61. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase activities of rat mammary tissue.
Mullaney I; Clegg RA
Biochem J; 1984 May; 219(3):801-9. PubMed ID: 6331397
[TBL] [Abstract][Full Text] [Related]
62. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
Nemecek GM; Butcher RW
J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
[TBL] [Abstract][Full Text] [Related]
63. [Effect of nucleoside triphosphates on cyclic nucleotide phosphodiesterase: role of protein modulators].
Garnovskaia MN; Dumler IL; Etingof RN
Biokhimiia; 1982 Feb; 47(2):221-5. PubMed ID: 6279182
[TBL] [Abstract][Full Text] [Related]
64. Purification and kinetic properties of two soluble forms of calmodulin-dependent cyclic nucleotide phosphodiesterase from rat pancreas.
Vandermeers A; Vandermeers-Piret MC; Rathe J; Christophe J
Biochem J; 1983 May; 211(2):341-7. PubMed ID: 6307278
[TBL] [Abstract][Full Text] [Related]
65. Cyclic nucleotide phosphodiesterase activity: histochemical and cytochemical methods.
Ueno S; Ueck M
Methods Enzymol; 1988; 159():477-89. PubMed ID: 2842613
[No Abstract] [Full Text] [Related]
66. Differential effects of various phosphodiesterase inhibitors, pyrimidine and purine compounds, and inorganic phosphates on cyclic CMP, cyclic AMP and cyclic GMP phosphodiesterases.
Helfman DM; Kuo JF
Biochem Pharmacol; 1982 Jan; 31(1):43-7. PubMed ID: 6277336
[TBL] [Abstract][Full Text] [Related]
67. Characterization of soluble uterine cyclic nucleotide phosphodiesterase.
Gardner EA; Thompson WJ; Strada SJ; Stancel GM
Biochemistry; 1978 Jul; 17(15):2995-3000. PubMed ID: 212098
[TBL] [Abstract][Full Text] [Related]
68. A rapid and precise assay for calmodulin and cyclic AMP phosphodiesterase on a centrifugal analyser.
Walker SW; Milner SW; Howie AF
Clin Chim Acta; 1987 May; 164(3):305-13. PubMed ID: 3036405
[TBL] [Abstract][Full Text] [Related]
69. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
Kuo JF; Shoji M; Brackett NL; Helfman DM
J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641
[TBL] [Abstract][Full Text] [Related]
70. Characterization of a calmodulin-dependent high-affinity cyclic AMP and cyclic GMP phosphodiesterase from male mouse germ cells.
Geremia R; Rossi P; Mocini D; Pezzotti R; Conti M
Biochem J; 1984 Feb; 217(3):693-700. PubMed ID: 6324744
[TBL] [Abstract][Full Text] [Related]
71. Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.
Torphy TJ; Cieslinski LB
Mol Pharmacol; 1990 Feb; 37(2):206-14. PubMed ID: 2154670
[TBL] [Abstract][Full Text] [Related]
72. Different sensitivites of cyclic nucleotide phosphodiesterases of rat brain and lung to inhibition by new anti-allergic chromones [proceedings].
Saeed SA; Butt NM; Spicer JW; Warren BT
Biochem Soc Trans; 1979 Dec; 7(6):1308-10. PubMed ID: 231533
[No Abstract] [Full Text] [Related]
73. Cyclic nucleotide phosphodiesterase. Insulin activation detected in adipose tissue by gel electrophoresis.
Solomon SS; Palazzolo M; King LE
Diabetes; 1977 Oct; 26(10):967-72. PubMed ID: 198322
[TBL] [Abstract][Full Text] [Related]
74. A new method for measurement of cyclic AMP phosphodiesterase activity.
Han GY; Han PF; Owen GS; Johnson J
J Biochem; 1977 Aug; 82(2):387-94. PubMed ID: 199581
[TBL] [Abstract][Full Text] [Related]
75. Characterization of the soluble cyclic nucleotide phosphodiesterases in Xenopus laevis oocytes. Evidence for a calmodulin-dependent enzyme.
Miot F; Erneux C
Biochim Biophys Acta; 1982 Feb; 701(2):253-9. PubMed ID: 6280770
[TBL] [Abstract][Full Text] [Related]
76. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
Donnelly TE; Barron B
Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
[TBL] [Abstract][Full Text] [Related]
77. Assay of cyclic nucleotide phosphodiesterase using radiolabeled and fluorescent substrates.
Kincaid RL; Manganiello VC
Methods Enzymol; 1988; 159():457-70. PubMed ID: 2842611
[No Abstract] [Full Text] [Related]
78. A reverse-phase HPLC method for cyclic nucleotide phosphodiesterases activity and classification.
Spoto G; Berardi S; Ajerba G; De Laurentiis V
Adv Exp Med Biol; 1994; 370():815-20. PubMed ID: 7661030
[No Abstract] [Full Text] [Related]
79. Modes of action of hypoxanthine, inosine and inosine 5'-monophosphate on cyclic nucleotide phosphodiesterase from bovine brain.
Liang CM; Liu YP; Chabner BA
Biochem Pharmacol; 1980 Feb; 29(3):277-82. PubMed ID: 6244836
[No Abstract] [Full Text] [Related]
80. Cyclic nucleotides and phosphodiesterases in platelets.
Haslam RJ; Dickinson NT; Jang EK
Thromb Haemost; 1999 Aug; 82(2):412-23. PubMed ID: 10605732
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
